Bryn Mawr Capital Management Inc’s Lifecore Biomedical LFCR Stock Holding History

Bryn Mawr Capital Management Inc’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-18,443	Closed	-$215K	–	168
2015 Q3	$215K	Buy	+18,443	New	+$244K	0.04%	419
2015 Q2	–	Sell	-20,046	Closed	-$280K	–	512
2015 Q1	$280K	Buy	+20,046	New	+$277K	0.04%	396
2014 Q2	–	Sell	-39,895	Closed	-$445K	–	629
2014 Q1	$445K	Sell	39,895 -4,137	-9%	-$45.4K	0.04%	387
2013 Q4	$534K	Sell	44,032 -2,500	-5%	-$29.9K	0.03%	326
2013 Q3	$568K	Buy	46,532 +16,726	+56%	+$233K	0.04%	261
2013 Q2	$394K	Buy	+29,806	New	+$412K	0.03%	265

Other funds holding LFCR

Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return

Bryn Mawr Capital Management Inc's LFCR Position: Q4 2015 in Review

Bryn Mawr Capital Management Inc sold out of Lifecore Biomedical (LFCR) in Q4 2015, closing a stake of 18,443 shares — an estimated $215K sold.

Bryn Mawr Capital Management Inc first reported a position in LFCR in Q2 2013 and held it in 6 quarters. The position peaked at $568K in Q3 2013. 109 funds tracked by Wall St. Rank hold LFCR as of Q4 2015.

Bryn Mawr Capital Management Inc reported no remaining Lifecore Biomedical position as of Q4 2015 after selling out during the quarter.
Bryn Mawr Capital Management Inc sold 18,443 Lifecore Biomedical shares in Q4 2015, an estimated $215K.
Bryn Mawr Capital Management Inc first reported a position in Lifecore Biomedical in Q2 2013 and held it in 6 quarters.
Bryn Mawr Capital Management Inc's Lifecore Biomedical position peaked at $568K in Q3 2013.
109 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2015.

Based on Bryn Mawr Capital Management Inc's 13F filing for Q4 2015.